ZUMZ — what changed in the latest 10-Q
A section-by-section comparison of ZUMZ's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-09-10 vs the prior 10-Q · 2026-06-04
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +10 | −3 | ~14 | 100 |
| Market risk (Item 3) | Text added/removed | 0 | 0 | ~1 | 0 |
| Controls & procedures | Text added/removed | 0 | 0 | ~2 | 0 |
| Legal proceedings | No paragraph-level changes | 0 | 0 | 0 | 2 |
| Risk factors | No material changes reported (points to the 10-K) | — | — | — | — |
| Other information | Text added/removed | 0 | −4 | ~1 | 0 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-09-10
Gross profit was $73.9 million for the three months ended August 1, 2026 compared to $76.0 million for the three months ended August 2, 2025, a decrease of $2.2 million, or 2.9%. As a percent of net sales, gross profit decreased 20 basis points for the three months ended August 1, 2026 to 35.3%. The…
Selling, general and administrative expense was $75.2 million for the three months ended August 1, 2026 compared to $75.9 million for the three months ended August 2, 2025, a decrease of $0.7 million, or 1.0%. SG&A expenses as a percent of net sales increased 50 basis points for the three months end…
Six Months (26 weeks) Ended August 1, 2026 Compared With Six Months (26 weeks) Ended August 2, 2025
Net sales were $402.3 million for the six months ended August 1, 2026, compared to $398.6 million for the six months ended August 2, 2025, an increase of $3.7 million, or 0.9%. The increase in sales was primarily driven by a 0.7% increase in comparable sales, partially offset by the net closure of 1…
Comparable sales increased 0.7% (reflecting a 0.4% increase in North America and a 2.1% increase in other international) for the six months ended August 1, 2026, driven by an increase in dollars per transaction, partially offset by a decrease in transactions. Dollars per transaction increased due to…
Text removed vs the prior filing · source: 10-Q · 2026-06-04
Gross profit was $61.3 million for the three months ended May 2, 2026 compared to $55.3 million for the three months ended May 3, 2025, an increase of $6.0 million, or 10.9%. As a percent of net sales, gross profit increased 170 basis points for the three months ended May 2, 2026 to 31.7%. The incre…
Selling, general and administrative expense was $76.5 million for the three months ended May 2, 2026 compared to $75.2 million for the three months ended May 3, 2025, an increase of $1.3 million, or 1.8%. SG&A expenses as a percent of net sales decreased 120 basis points for the three months ended M…
Net cash used in investing activities increased by $22.1 million to $26.3 million used in investing activities for the three months ended May 2, 2026 from $4.2 million used in investing activities for the three months ended May 3, 2025. Net cash used in investing activities was $26.3 million for the…
Other information
Text removed vs the prior filing · source: 10-Q · 2026-06-04
defined in Item 408(a) of SEC Regulation S-K, except as described below:
On April 15, 2026, Mr. Chris K. Visser, the Company’s Chief Legal Officer and Secretary, terminated a previously disclosed trading arrangement and adopted a new trading arrangement that is intended to satisfy the affirmative defense conditions of Rule 10b5‑1(c) under the Securities Exchange Act of 1…
On April 17, 2026, Mr. Christopher C. Work, the Company’s Chief Financial Officer, terminated a previously disclosed trading arrangement and adopted a new trading arrangement that is intended to satisfy the affirmative defense conditions of Rule 10b5‑1(c) under the Securities Exchange Act of 1934. T…
On April 20, 2026, Ms. Erin Wendte, the Company’s Chief Commercial Officer, adopted a trading arrangement that is intended to satisfy the affirmative defense conditions of Rule 10b5‑1(c) under the Securities Exchange Act of 1934. The trading arrangement has a termination date of April 30, 2027, and …
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice